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Abstract Intracerebral microdialysis in conjunction with
a highly sensitive radioimmunoassay was used to study the
in vivo release of neuropeptide S (NPS) within the amyg-
dala of freely moving rats. NPS was consistently detected
in basolateral amygdala dialysates and the release consid-
erably enhanced in response to local depolarisation as well
as exposure to forced swim stress. Thus, our data demon-
strate for the ﬁrst time emotional stress-induced release of
NPS in the amygdala supporting a functional role of
endogenous NPS in stress/anxiety-related phenomena.
Keywords Neuropeptide S antibody  Anxiety 
Depression  Stress-related disorders  Microdialysis 
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Introduction
The recently discovered neuropeptide S (NPS) and its cog-
nate receptor (NPSR) have been found to be involved in
various behavioral functions including stress and fear/anxi-
ety reactions (for review see Okamuraand Reinscheid2007;
Pape et al. 2010). Considerable evidence suggests that the
amygdala may be a critical site of action for NPS mediating
stress and anxiety mechanisms. This idea was initiallybased
on anatomical ﬁndings demonstrating a high density of
NPSR mRNA expression in the amygdala of rats and mice
(Xuetal.2004,2007;Ju ¨nglingetal.2008;LeonardandRing
2011). Within the murine amygdala NPSR were found in
several subdivisions including the lateral (LA) and basal
(BA) amygdala (Ju ¨ngling et al. 2008; Clark et al. 2011).
Furthermore, the two brain stem sites containing NPS-syn-
thesizing neurons give rise to NPS-immunopositive ﬁbers,
which overlap well with NPSR mRNA expression (Clark
et al. 2011). However, the exact distribution of NPS ﬁbers
and terminals within the amygdala of rodents has not been
studied adequately so far. The high abundance of binding
sites within the amygdala of rats and mice suggests that the
NPS system may play a crucial role in multiple amygdala
functions such as controlling emotional processes. Indeed,
behavioralstudies inmice have shown that fear andanxiety-
related behaviors are reduced after intraamygdaloid admin-
istration of NPS (Ju ¨ngling et al. 2008; Fendt et al. 2010).
Conversely, the injection of a selective NPSR antagonist
into the amygdala exerts functionally opposing responses,
an increase of anxiety-related behavior, suggesting an
involvement of endogenous NPS in behavioral regulation
(Ju ¨ngling et al. 2008). Thus, these studies support the idea
that NPS acts as a neurotransmitter/neuromodulator in the
amygdala to mediate emotional processes including stress
and anxiety mechanisms. Forced swim stress in mice was
indeed found to increase c-fos activity in NPS-synthesizing
neurons in the brain stem (Liu et al. 2011), implying that the
NPS system may be stimulated upon stress exposure. How-
ever, direct evidence for such a role from in vivo sampling
measurementssuchasmicrodialysisthatenablesmonitoring
neurotransmitter/neuromodulator release within distinct
brain areas of freely behaving animals is still missing.
Measurements of the release of NPS in the amygdala in
response to stressful and aversive stimuli would present
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romodulator function of NPS within this limbic area under
physiologically relevant conditions.
In the present study, we describe the use of intracerebral
microdialysis in combination with a sensitive radioimmu-
noassay to monitor the neuronal efﬂux of NPS in the rat
amygdala under basal and depolarizing conditions. Fur-
thermore, we investigated whether a stressful and anxiety-
provoking situation such as exposure to forced swimming
would also be sufﬁcient to trigger NPS release in the
amygdala.
Materials and methods
Animals
Experiments were carried out on adult male Sprague–
Dawley rats (300–350 g). Prior to use, the animals were
housed in groups of 4–6 under controlled laboratory con-
ditions (12:12 h light/dark cycle with lights on at 7:00
A.M., 21 ± 1C, 60% humidity, pelleted food and water
ad libitum) for at least one week after delivery from the
supplier. All experiments were approved by the local
Ethics Committee on Animal Care and Use of the Austrian
governmental body (Bundesministerium fu ¨r Wissenschaft
and Verkehr, Kommission fu ¨r Tierversuchsangelegenhei-
ten, Ref No: BMWF-66.008/0014-II/10b/2010).
Surgery
Rats were anesthetized by intraperitonal injections of
sodium pentobarbital (40 mg/kg) and ketamine (50 mg/kg)
and a microdialysis probe was stereotaxically implanted
according to the brain atlas of Paxinos and Watson (1998).
The probe consisting of an 18-kDa dialysis membrane
(Hemophan, Membrana, Wuppertal, Germany) with an
active surface length of 1 mm was positioned with its
U-shaped tip reaching the right basal/lateral amygdala
(BA/LA) (Fig. 1; implantation coordinates: 2.8 mm caudal
to bregma, 2.5 mm lateral to the midline, 9.2 mm below
the surface of the skull with an angle of 15). The probe
was ﬁxed to the skull with two jeweler’s screws and dental
cement. The two endings of the probe were attached to
5-cm long pieces of polyethylene tubing for connection
with the infusion pump. Postoperatively, rats were treated
with Buprenorphine (0.1 mg/kg body weight, s.c. every
8 h) and housed individually in transparent plexiglas cages.
They were handled for 3 min twice daily to familiarize
them with the experimental procedure and to minimize
nonspeciﬁc stress responses during the experiments. At
least 24 h before the experiment, animals were kept in the
experimental room and allowed to habituate.
Microdialysis procedure
Two days after surgery, the implanted microdialysis probe
was connected to a syringe mounted onto a microinfusion
pump and superfused with artiﬁcial cerebrospinal ﬂuid
(aCSF: 140 mM NaCl, 3.0 mM KCl, 1.25 mM CaCl2,
1.0 mM MgCl2, 1.2 mM Na2HPO4, 0.3 mM NaH2PO4 and
3.0 mM glucose, pH 7.2) at a ﬂow rate of 4 ll/min. To
minimize the binding of NPS to the plastic surfaces and to
reduce peptidase activity, bovine serum albumin (0.2%)
and bacitracin (0.03%) were included in the perfusion
medium. Microdialysis probes were initially dialyzed for
120 min to establish an equilibration between the inside
and outside of the microdialysis membrane. During this
equilibration period, sample collection was simulated every
30 min to adapt animals to the microdialysis procedure but
dialysates were discarded. Thereafter, various consecutive
30-min dialysates were collected directly into Eppendorf
vials, which were stored at -80C until assay.
Experimental protocol
In the ﬁrst series of experiments, perfusion with high
potassium-containing aCSF was used to elicit local depo-
larization. Three basal 30-min samples were collected after
a 120-min equilibration period. Subsequently, probes were
dialyzed with aCSF containing 100 mM KCl for a further
30-min period. During these experiments, rats remained in
their home cages.
In the second series of experiments, we investigated the
effects of stress exposure on NPS release. Therefore, rats
were dialyzed initially with aCSF for 120 min to collect
four baseline samples in their home cages. At the begin-
ning of the ﬁfth dialysis interval, animals were transferred
from their home cage to a swim tank (square plastic tank,
35 9 35 9 42 cm; ﬁlled with water at 20C up to a height
of 30 cm) for 10 min with ongoing microdialysis. There-
after, they were gently dried using a towel and returned to
their home cage. After stress exposure, dialysis was con-
tinued for further 140 min when rats were undisturbed
within their home cages. At the end of each experiment,
animals were disconnected from the microdialysis lines
and blank samples (e.g. aCSF and aCSF containing
100 mM KCl) were collected that were run as blank con-
trols in the same analysis as the sample microdialysates.
Histology
At the end of the experiment, the animals were killed by an
overdose of pentobarbital (600 mg/kg) and their brains
removed. For histological veriﬁcation of the localization
of the microdialysis probes, brains were sectioned and
40 lm coronal sections were stained with cresyl violet.
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(Fig. 1) were determined on the basis of previous deﬁni-
tions of a brain atlas (Paxinos and Watson 1998). Judgment
of successful implantation of probes into the amygdala was
made before analyzing data from release experiments.
Quantiﬁcation of NPS in microdialysates
The concentration of NPS was measured in microdialy-
sates by a highly sensitive and selective radioimmunoas-
say. As the sensitivity of the antibody is a critical
component of the radioimmunological measurement, we
performed various standard curves using different com-
mercially available polyclonal rabbit antisera to rat NPS
(Table 1). The used assay system was further optimized
by performing antibody dilution curves which involves the
incubation of a ﬁxed amount of tracer with different
concentrations of antibody to determine the amount of
antibody optimal for use in a microdialysate-relevant
standard curve. In each assay, known amounts of synthetic
NPS (H-6164, Bachem) were serially diluted (0.5, 1, 2, 4,
8, 16, 32, 64, 128 pg/100 ll RIA buffer) and preincubated
with 100 ll of 1:50 diluted NPS-antiserum for 48 h at 4C
before the tracer ligand (Bachem) was added. We found
that the antibody T-4808 (Bachem) has sufﬁcient
sensitivity to be used for setting up a standard curve in
the desired concentration range (Table 1). This antibody
has been shown to display no cross-reactivity with
other structurally related peptides such as human NPS that
has only minor differences in amino acid sequence
(http://www.bachem.com). After addition of 100 ll radio-
iodinated NPS (approximately 8,000 cpm in 100 ll), all
samples were further incubated for 48 h at 4C. Antibody-
bound radioligand was separated from unbound radioli-
gand by addition of charcoal (1 ml) and centrifugation
(2,0569g for 10 min at 4C). The supernatant was dec-
anted, and the bound radioactivity was counted in a
gamma counter. The detection limit of the assay was
about 0.1 pg per sample (=1 pg/ml).
Statistics
Statistical analysis was performed using a computer soft-
ware package (GB-Stat 6.0, Dynamic Microsystems, Silver
Springs, USA). Data were expressed as raw data and sub-
mitted to a one-way (high KCl experiments) or two-way
ANOVA with repeated measures (group x time, forced
swim experiments) followed by appropriate post hoc anal-
ysis. Thereby, NPS levels during and after high potassium
or forced swimming were compared with each single point
BA
LA
A
B
-3.1 mm -2.6 mm
Fig. 1 Probe placements in the
amygdala. a A representative
photomicrograph of a cresyl-
stained coronal section showing
the localization of the tip of the
membrane of a microdialysis
probe (arrowhead) within the
BA/LA. b Schematic drawings
of the localization of the
microdialysis membranes (bold
black lines) used in the present
study within and outside of the
BA/LA. BA basal amygdala, LA
lateral amygdala. Illustrations
modiﬁed from Paxinos and
Watson (1998)
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niﬁcance was accepted if P\0.05.
Results
Effect of high KCl on the release of NPS
within the amygdala
The NPS content of dialysates collected in the BA/LA
under basal conditions was consistently above the detec-
tion limit of the radioimmunoassay, reaching an average
concentration of 1.7 ± 0.5 pg/dialysate (N = 9). Although
histological analysis of probe placement revealed that in
all 11 animals of this experiment probes were placed
within the BA/LA, two animals had to be excluded from
the study because basal levels were under the detection
limit of the assay. As illustrated in Fig. 2a, administration
of 100 mM KCl in the perfusion medium for 30 min
caused an 500% increase in extracellular NPS concentra-
tion yielding dialysate levels of 8.5 ± 2.0 pg/dialysate
(one-way ANOVA F3,24 = 11.35, P\0.0001). During
perfusion with high KCl we observed no behavioral
abnormalities. Moreover, an interference of KCl solution
with RIA analysis can be excluded because no detectable
NPS levels were measured in the analysis of blank sam-
ples (see above).
Effects of forced swimming on the release of NPS
within the amygdala
Histological analysis of probe placement revealed that 11
out of 17 probes were placed within the BA/LA whereas 6
were localized outside the amygdala, 3 within the internal
capsule and 3 within the lateral hypothalamus. The basal
level of NPS within the BA/LA before stress exposure was
2.5 ± 0.3 pg/dialysate (N = 11). For comparison, the basal
NPS levels in the internal capsule and lateral hypothalamus
were 0.7 ± 0.2 and 2.3 ± 0.2, respectively. For statistical
comparison all outsiders were summarized in one group. As
showninFig. 2b,swimstresscausedasigniﬁcantincreasein
the NPS content of microdialysates collected from the BA/
LA amounting to 200% of the basal release. Statistical
analysis by two-way ANOVA revealed a signiﬁcant differ-
ence in NPS release patterns between animals with correct
probe placement within the amygdala and animals where
probe placements were localized outside the amygdala
(group: F1,15 = 11.97, P = 0.0035; time: F8,120 = 2.43,
P = 0.018;interactionbetweenmainfactors:F8,120 = 3.59,
P = 0.0009). Post hoc analysis revealed a signiﬁcant
Table 1 Comparison of different commercially available antibodies used in this study
Code Source B0 (%) ED80 (pg/tube) ED50 (pg/tube) ED20 (pg/tube)
ab-1852 Abcam 11.7 n.d. n.d. n.d.
S-2201 Bachem 34.9 2.9 10.2 36.1
T-4808 Bachem 28.3 1.6 8.3 42.2
B0 maximal binding, n.d. not detectable because ab-1852 failed to displace tracer at concentrations used for the standard curve ED20 50 80: 80, 50
and 20% displacement of tracer
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Fig. 2 NPS release within the amygdala. a Effect of high potassium
and b forced swimming on the content of NPS in 30-min microdi-
alysates sampled consecutively within (solid circles) or outside (open
circles) the amygdala of freely moving rats. Animals were perfused
with aCSF containing 100 mM KCl (black bar) or exposed to forced
swimming (FS; gray-shaded bar) for 10 min during the fourth or ﬁfth
dialysis interval, respectively. Data expressed as mean ? SEM.
**P\0.01 versus respective baseline;
#P\0.05,
##P\0.01 versus
respective value in the ‘outsider’ group (Newman–Keuls post hoc
test)
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123increase of NPS efﬂux during and after stress exposure only
in animals with correct probe placement within the amyg-
dala. Notably, the stress-evoked NPS release reached a peak
level 60 min after onset of the stressor and returned to pre-
stress values about 90 min after stress exposure. In contrast,
NPS-content in microdialysates sampled outside the amyg-
dalaeitherintheinternalcapsuleorlateralhypothalamusdid
notincreaseduringstressexposureandremainedunchanged
throughout the entire dialysis period (Fig. 2b).
Discussion
Theresultsofthepresentstudydemonstrate fortheﬁrsttime
that NPS release within the amygdala can be monitored in
conscious rats both under stimulated and basal/resting con-
ditions by using microdialysis in conjunction with a highly
sensitiveradioimmunoassay.NPSrelease intheBA/LA was
considerably enhanced in response to local high potassium-
induced depolarisation as well as stressfull situation by
exposure of rats to forced swimming. Notably, the latter
effectwasfoundonlyinanimalswheremicrodialysisprobes
were localized within the amygdala region and not in sur-
rounding areas such as internal capsule and lateral hypo-
thalamus. Thus, a contamination of ‘‘functional-relevant’’
NPSfromthesesurroundingareascanbeexcluded,although
detectable basal NPS levels were found in both areas.
The investigation of the in vivo efﬂux of neuropeptides
such as NPS by microdialysis is particularly challenging
and is hampered by the low concentrations of these mol-
ecules in the extracellular ﬂuid (ranging from sub pico- to
femtomolar levels), the low recovery of peptides via
microdialysis sampling (\10% typically) and the small
volume of dialysates generated. Thus, it needs extremely
sensitive analytical procedures to determine NPS in micro-
dialysates. In our study we used a novel, highly sensitive
radioimmunoassay developed from a protocol we have used
for the detection of other neuropeptides such as substance P
(Ebner et al. 2004). Besides the need of a highly sensitive
analytical technique, the optimization of microdiaysis
recovery was just as important as enhancing method sensi-
tivity to quantify NPS in microdialysates. However, the
recovery for any analyte in microdialysis sampling is a
complex process that may be inﬂuenced by several param-
eters, including ﬂow rate, probe geometry as well as mem-
brane properties (e.g. length, material). Concerning probe
geometry we used a U-shaped cannula design because of its
improved recovery properties compared with the concentric
one (Horn and Engelmann 2001). To identify the membrane
type with the optimal recovery for NPS, we compared three
different membranes (cuprophane, hemophane and polye-
thersulfone) for their efﬁciency in recovering NPS.
Although recovery differences between membranes were
minimal, the most efﬁcient membrane types were polye-
thersulfone and hemophane. However, due to the brittle and
fragile properties of the polyethersulfone ﬁber, making it
difﬁcult to use with a U-shaped cannula design, we used
hemophane probes for our in vivo experiments. The reliable
measurement of NPS in microdialysates was likely
improved by the addition of BSA to the perfusion medium
which has been shown to be efﬁcient in minimizing non-
speciﬁc adsorption of sticky neuropeptides to glass and
plastic surfaces (Kendrick 1990). Moreover, a further pre-
caution against a loss of the already low peptide levels in
microdialysis samples was the addition of the peptidase
inhibitor bacitracin to the perfusion ﬂuid to minimize
enzymatic breakdown.
In summary, the present results evaluated the possibility
of applying microdialysis for monitoring NPS release in
distinct brain areas of freely moving rats. Thus, we could
demonstrate for the ﬁrst time that this method in combi-
nation with highly sensitive analytical procedures is a
suitable tool to investigate the characteristics and dynamic
changes of centrally released NPS. Our data also support
the notion that NPS acts as part of neurotransmitter/neu-
romodulator systems that are stimulated in response to a
stressor. In line with this conclusion is the previous ﬁnding
that forced swim stress increases c-fos activity in NPS-
positive neurons in the brain stem (Liu et al. 2011). Since
the amygdala is considered a critical site for transforming
stressful events into anxiety (Roozendaal et al. 2009), our
data also suggest that stress-induced NPS release within the
amygdala can modulate stress and anxiety responsiveness.
Along these lines, it was recently reported that a functional
polymorphism in the NPSR gene changes amygdala
responsiveness to aversive stimuli potentially contributing
to anxiety traits (Dannlowski et al. 2011). Considering this
evidence of a possible involvement of NPS in the etiology
of anxiety disorders in humans (see also Donner et al.
2010; Domschke et al. 2011), it seems that interfering with
this NPS-mediated pathway may have therapeutic rele-
vance in psychopathologies including anxiety disorders.
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